$199.020
-6.986 (-3.51%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de AXSM por análisis de gráficos similares
Alphio's AXSM stock price prediction model matches the current Axsome Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $199.52 (+0.25%). The 1-week path is $212.91 (+6.98%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Axsome Therapeutics, Inc.?
Axsome Therapeutics is currently a hold. The stock has a current price of $199.02 and an RSI of 19.79, indicating it is oversold. However, the forward P/E ratio is extremely high at 370.37, suggesting that the stock may be overvalued at this time. While the company reported a strong 46% year-over-year revenue increase in Q2, reaching $218.4 million, and has a gross margin of 93.06%, the significant net losses and high forward P/E ratio raise concerns about its valuation. The main risk is the high forward P/E ratio of 370.37, which could indicate that the stock is overvalued if growth does not meet expectations.
AXSM cerró en $199.02 el Friday, tras bajar -3.51%
Axsome Therapeutics, Inc. (AXSM) last closed at $199.02, losing -3.51%. These facts feed the 1-day and 1-week AXSM price prediction above.
Consenso de analistas
Axsome Therapeutics, Inc. (AXSM): 2 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Axsome Therapeutics, Inc. (AXSM) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de AXSM, ordenadas por similitud.
Análisis de estacionalidad de AXSM
Historically the probability of a positive August return for AXSM is 100.00%. July offers the highest probability of a positive month at 100.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de AXSM
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $144.74 | $170.05 | $171.67 | -14.55% |
| Sep 2026 | $109.47 | $151.76 | $167.90 | -23.75% |
| Oct 2026 | $183.47 | $198.72 | $241.76 | -0.15% |
| Nov 2026 | $155.82 | $198.72 | $211.41 | -0.15% |
| Dec 2026 | $131.38 | $153.74 | $200.39 | -22.75% |
En 2026, se proyecta que Axsome Therapeutics, Inc. (AXSM) oscile entre $109.47 y $241.76.
Previsión mensual de Axsome Therapeutics, Inc. para 2026
En Aug de 2026, se proyecta que Axsome Therapeutics, Inc. promedie $170.05, con un mínimo de $144.74 y un máximo de $171.67.
En Sep de 2026, se proyecta que Axsome Therapeutics, Inc. promedie $151.76, con un mínimo de $109.47 y un máximo de $167.90.
En Oct de 2026, se proyecta que Axsome Therapeutics, Inc. promedie $198.72, con un mínimo de $183.47 y un máximo de $241.76.
En Nov de 2026, se proyecta que Axsome Therapeutics, Inc. promedie $198.72, con un mínimo de $155.82 y un máximo de $211.41.
En Dec de 2026, se proyecta que Axsome Therapeutics, Inc. promedie $153.74, con un mínimo de $131.38 y un máximo de $200.39.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.